We are proud to announce the successful completion of 24-months of follow-up for the IMAGE trial, a landmark study evaluating the role of Melanoma Surveillance Photography (MSP) in improving early detection of melanoma among high and ultra-high-risk patients. This milestone marks a significant step in assessing the long-term impact of MSP on reducing unnecessary biopsies and improving diagnostic accuracy.

“The IMAGE trial addresses a critical evidence gap for the use of total body photography in surveillance of people with melanoma and will help to inform best practice in future”, said Chief Investigator Prof Victoria Mar, Monash University.

With further analysis underway, data from the trial, sponsored by Monash and coordinated by our MASC Research Centre, will be instrumental in informing future recommendations for melanoma care and guiding decisions around public funding for MSP services.

“Sincere thanks to all participants, clinicians, and research teams from 11 sites nationally, whose dedication has made this achievement possible”, said Katja Loewe, MASC Trials Research Manager.

Prof Mar is Director of the Victorian Melanoma Service at The Alfred, Co-Head of the SkIIN Discovery Program, a Monash University and The Alfred partnership, and an NHMRC Early Career Fellow at the School of Public Health and Preventive Medicine, Monash University.

Learn more about the IMAGE trial.